Toggle Main Menu Toggle Search

Open Access padlockePrints

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing

Lookup NU author(s): Dr Kirsty McAleese, Dr Lauren WalkerORCiD, Dr Daniel ErskineORCiD, Professor Alan ThomasORCiD, Professor Ian McKeith, Professor Johannes Attems


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2016 International Society of Neuropathology. Intracellular inclusions consisting of TAR DNA binding protein-43 (TDP-43 pathology) are present in up to 57% of Alzheimer's disease (AD) cases and follow a distinct topographical pattern of progression described in the TDP-43 in AD staging scheme. This scheme has not been applied to the assessment of TDP-43 pathology in dementia with Lewy bodies (DLB) and aged controls. We investigated TDP-43 pathology prevalence and severity in AD, DLB, mixed AD/DLB (Mx AD/DLB) and aged controls. One hundred and nineteen human post-mortem brains were included, neuropathologically diagnosed as AD: 46, DLB: 15, Mx AD/DLB: 19 and aged controls: 39. Paraffin sections inclusive of the amygdala, hippocampus, striatum and neocortex were immunohistochemically stained with antibodies against phosphorylated TDP-43 and staged according to the TDP-43 in AD staging scheme. TDP-43 pathology was present in all groups: AD: 73.9%, DLB: 33.3%, Mx AD/DLB: 52.6% and controls: 17.9%. Prevalence of TDP-43 pathology was significantly higher in AD and Mx AD/DLB compared to controls. In controls, higher age at death was associated with prevalence of TDP-43 pathology and higher TDP-43 in AD stage, suggesting that this type of TDP-43 pathology may partly be an age-associated phenomenon. Significantly higher prevalence of TDP-43 pathology in the AD group indicates that AD pathology possibly triggers and aggravates TDP-43 pathology. The validity of the TDP-43 in AD staging scheme is not limited to AD and should be applied to assess TDP-43 pathology in post mortem brains of aged individuals to further elucidate the role of TDP-43 pathology in age associated neurodegeneration.

Publication metadata

Author(s): Mcaleese KE, Walker L, Erskine D, Thomas AJ, Mckeith IG, Attems J

Publication type: Article

Publication status: Published

Journal: Brain Pathology

Year: 2017

Volume: 27

Issue: 4

Pages: 472-479

Print publication date: 01/07/2017

Online publication date: 06/08/2016

Acceptance date: 01/08/2016

ISSN (print): 1015-6305

ISSN (electronic): 1750-3639

Publisher: Wiley-Blackwell


DOI: 10.1111/bpa.12424


Altmetrics provided by Altmetric